Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Serum 25-hydroxyvitamin D, vitamin A, and lung cancer mortality in the US population: a potential nutrient-nutrient interaction.

Cheng TY, Neuhouser ML.

Cancer Causes Control. 2012 Sep;23(9):1557-65. doi: 10.1007/s10552-012-0033-8. Epub 2012 Jul 25.

PMID:
22829430
2.

The inverse association between serum 25-hydroxyvitamin D and mortality may be modified by vitamin A status and use of vitamin A supplements.

Schmutz EA, Zimmermann MB, Rohrmann S.

Eur J Nutr. 2016 Feb;55(1):393-402. doi: 10.1007/s00394-015-0860-y. Epub 2015 Feb 21.

PMID:
25701092
3.

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial.

Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL Jr, Valanis B, Williams JH Jr, Barnhart S, Cherniack MG, Brodkin CA, Hammar S.

J Natl Cancer Inst. 1996 Nov 6;88(21):1550-9.

4.

Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults.

Ginde AA, Scragg R, Schwartz RS, Camargo CA Jr.

J Am Geriatr Soc. 2009 Sep;57(9):1595-603. doi: 10.1111/j.1532-5415.2009.02359.x. Epub 2009 Jun 22.

PMID:
19549021
5.

Serum retinoids and beta-carotene as predictors of hip and other fractures in elderly women.

Barker ME, McCloskey E, Saha S, Gossiel F, Charlesworth D, Powers HJ, Blumsohn A.

J Bone Miner Res. 2005 Jun;20(6):913-20. Epub 2005 Jan 24.

6.

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance.

Albanes D, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, Hartman AM, Palmgren J, Freedman LS, Haapakoski J, Barrett MJ, Pietinen P, Malila N, Tala E, Liippo K, Salomaa ER, Tangrea JA, Teppo L, Askin FB, Taskinen E, Erozan Y, Greenwald P, Huttunen JK.

J Natl Cancer Inst. 1996 Nov 6;88(21):1560-70.

PMID:
8901854
7.

Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.

Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, Holleczek B, Brenner H.

Am J Clin Nutr. 2013 Apr;97(4):782-93. doi: 10.3945/ajcn.112.047712. Epub 2013 Feb 27.

8.
10.

Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients.

Zhou W, Heist RS, Liu G, Asomaning K, Neuberg DS, Hollis BW, Wain JC, Lynch TJ, Giovannucci E, Su L, Christiani DC.

J Clin Oncol. 2007 Feb 10;25(5):479-85.

PMID:
17290055
11.

Vitamin D and all-cause mortality among adults in USA: findings from the National Health and Nutrition Examination Survey Linked Mortality Study.

Ford ES, Zhao G, Tsai J, Li C.

Int J Epidemiol. 2011 Aug;40(4):998-1005. doi: 10.1093/ije/dyq264. Epub 2011 Jan 25.

PMID:
21266455
12.

Prospective study of serum vitamin D and cancer mortality in the United States.

Freedman DM, Looker AC, Chang SC, Graubard BI.

J Natl Cancer Inst. 2007 Nov 7;99(21):1594-602. Epub 2007 Oct 30.

PMID:
17971526
13.

Dietary and serum alpha-tocopherol, beta-carotene and retinol, and risk for colorectal cancer in male smokers.

Malila N, Virtamo J, Virtanen M, Pietinen P, Albanes D, Teppo L.

Eur J Clin Nutr. 2002 Jul;56(7):615-21.

14.

Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study.

Zhao G, Ford ES, Li C, Croft JB.

J Hypertens. 2012 Feb;30(2):284-9. doi: 10.1097/HJH.0b013e32834e1f0a.

PMID:
22179077
15.

Plasma retinol and total carotenes and fracture risk after long-term supplementation with high doses of retinol.

Ambrosini GL, Alfonso H, Reid A, Mackerras D, Bremner AP, Beilby J, Olsen NJ, Musk AW, de Klerk NH.

Nutrition. 2014 May;30(5):551-6. doi: 10.1016/j.nut.2013.10.007. Epub 2013 Oct 16.

PMID:
24698346
16.

Dietary beta carotene and lung cancer risk in U.S. nonsmokers.

Mayne ST, Janerich DT, Greenwald P, Chorost S, Tucci C, Zaman MB, Melamed MR, Kiely M, McKneally MF.

J Natl Cancer Inst. 1994 Jan 5;86(1):33-8.

PMID:
8271280
17.

Prediagnostic levels of serum beta-cryptoxanthin and retinol predict smoking-related lung cancer risk in Shanghai, China.

Yuan JM, Ross RK, Chu XD, Gao YT, Yu MC.

Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):767-73.

18.

Serum vitamin D, vitamin D binding protein, and lung cancer survival.

Anic GM, Weinstein SJ, Mondul AM, Männistö S, Albanes D.

Lung Cancer. 2014 Dec;86(3):297-303. doi: 10.1016/j.lungcan.2014.10.008. Epub 2014 Oct 20.

19.

The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.

Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL Jr, Omenn GS, Valanis B, Williams JH Jr.

J Natl Cancer Inst. 2004 Dec 1;96(23):1743-50.

20.

Serum levels of vitamin D are not associated with future risk of venous thromboembolism. The Tromsø Study.

Brodin E, Lerstad G, Grimnes G, Brækkan SK, Vik A, Brox J, Svartberg J, Jorde R, Hansen JB.

Thromb Haemost. 2013 May;109(5):885-90. doi: 10.1160/TH12-10-0728. Epub 2013 Feb 28.

PMID:
23446951

Supplemental Content

Support Center